The value on SUV-derived parameters assessed on 18F-FDG PET/CT for predicting mediastinal lymph node metastasis in non-small cell lung cancer

Abstract Purpose To explore valuable predictors for mediastinal lymph node metastasis in non-small cell lung cancer (NSCLC) patients, we analyzed the potential roles of standardized uptake value (SUV)-derived parameters from preoperative 18F-FDG PET/CT combined with clinical characteristics. Methods...

Full description

Bibliographic Details
Published in:	BMC Medical Imaging
Main Authors:	Xuhe Liao, Meng Liu, Shanshi Li, Weiming Huang, Cuiyan Guo, Jia Liu, Yan Xiong, Jianhua Zhang, Yan Fan, Rongfu Wang
Format:	Article
Language:	English
Published:	BMC 2023-04-01
Subjects:	NSCLC Mediastinal lymph node metastasis 18F-FDG SUV SUVpeak Tumor marker
Online Access:	https://doi.org/10.1186/s12880-023-01004-7

Similar Items

18F-FAPI PET/CT performs better in evaluating mediastinal and hilar lymph nodes in patients with lung cancer: comparison with 18F-FDG PET/CT
by: Yuyun Sun, et al.
Published: (2024-01-01)

Safety injections of nuclear medicine radiotracers: towards a new modality for a real-time detection of extravasation events and 18F-FDG SUV data correction
by: Mauro Iori, et al.
Published: (2023-05-01)

Evaluation of mediastinal lymph nodes using <sup>18</sup> F-FDG PET-CT scan and its histopathologic correlation
by: Kumar Arvind, et al.
Published: (2011-01-01)

Prevalence and Significance of FDG-avid Mediastinal Lymph Nodes in Patients with Colorectal Cancer in a Tuberculosis-endemic Area
by: Yutapong Raruenrom, et al.
Published: (2022-02-01)

U-Net-based SUV calculation in FDG-PET imaging of mice brain for enhanced analysis
by: Pashazadeh Ali, et al.
Published: (2023-09-01)

Exploration of the threshold SUV for diagnosis of malignancy using 18F-FBPA PET/CT
by: Kayako Isohashi, et al.
Published: (2022-12-01)

CT-SEGMENTED BONE SUV IN MULTIPLE MYELOMA: A COMPARATIVE STUDY OF ¹⁸F-FDG AND ⁶⁸GA-PSMA PET/CT
by: Alexandre Mercuri Barbosa, et al.
Published: (2025-05-01)

18F-FDG-Uptake in Mediastinal Lymph Nodes in Suspected Prosthetic Valve Endocarditis: Predictor or Confounder?
by: Derk ten Hove, et al.
Published: (2021-08-01)

The Association between the Body Mass Index, Chronic Obstructive Pulmonary Disease and SUV of the Non-Tumorous Lung in the Pretreatment [<sup>18</sup>F]FDG-PET/CT of Patients with Lung Cancer
by: Lukas Wehlte, et al.
Published: (2024-05-01)

Head-to-head study of [18F]FAPI-04 PET/CT and [18F]FDG PET/CT for non-invasive assessment of liver cancer and its immunohistochemical markers
by: Zhiying Liang, et al.
Published: (2024-11-01)

Potentials of Non-Invasive 18F-FDG PET/CT in Immunotherapy Prediction for Non–Small Cell Lung Cancer
by: Xuhe Liao, et al.
Published: (2022-02-01)

Applicability of [18F]FDG/PET for investigating rosmarinic acid preconditioning efficacy in a global stroke model in mice
by: Elaine Vasconcelos dos Santos, et al.
Published: (2023-05-01)

Assessment of the effect of hepatic steatosis on 18F-FDG uptake in PET-CT examinations and its relation with the body mass index (BMI)
by: Mennatallah Elkattan, et al.
Published: (2025-04-01)

Clinico-biological-radiomics (CBR) based machine learning for improving the diagnostic accuracy of FDG-PET false-positive lymph nodes in lung cancer
by: Caiyue Ren, et al.
Published: (2023-12-01)

Diagnostic Accuracy of PET/CT in Detecting Aggressiveness of Lymphoma Based on Sub Uptake
by: Sana waqar, et al.
Published: (2023-04-01)

Reevaluation Body Weight and Age with Standardized Uptake Value in the Liver Cancer for [18F] FDG PET/CT
by: Aya B. Hade, et al.
Published: (2023-06-01)

[18F]FDG PET/CT and PET/MR in Patients with Adrenal Lymphoma: A Systematic Review of Literature and a Collection of Cases
by: Laura Evangelista, et al.
Published: (2022-10-01)

When SUV Matters: FDG PET/CT at Baseline Correlates with Survival in Soft Tissue and Ewing Sarcoma
by: Ruben I. Hack, et al.
Published: (2021-08-01)

Influence of metabolic tumor burden on reference tissues’ standardized uptake values in 18F-FDG PET/CT sequential imaging
by: Ahmed Badawy, et al.
Published: (2023-11-01)

A diagnostic model based on 18F-FDG PET/CT parameters in improving the differential diagnosis of invasive thymic epithelial tumors and anterior mediastinal lymphomas
by: Shuo Zhou, et al.
Published: (2024-01-01)

Assessment of Therapeutic Response in Pyogenic Vertebral Osteomyelitis Using <sup>18</sup>F-FDG-PET/MRI
by: Ikchan Jeon, et al.
Published: (2020-11-01)

Dynamic FDG-PET imaging for differentiating metastatic from non-metastatic lymph nodes of lung cancer
by: Xieraili Wumener, et al.
Published: (2022-11-01)

Semi-Quantitative and Quantitative [<sup>18</sup>F]FDG-PET/CT Indices for Diagnosing Large Vessel Vasculitis: A Critical Review
by: Olivier Gheysens, et al.
Published: (2021-12-01)

Head-to-head comparison of 18F-FDG PET/CT and 18F-FDG PET/MRI for lymph node metastasis staging in non-small cell lung cancer: a meta-analysis
by: Min Zhang, et al.
Published: (2024-03-01)

Optimized 18F-FDG PET-CT Method to Improve Accuracy of Diagnosis of Metastatic Cancer
by: Richard Black, et al.
Published: (2023-04-01)

The Additional Role of F18-FDG PET/CT in Characterizing MRI-Diagnosed Tumor Deposits in Locally Advanced Rectal Cancer
by: Mark J. Roef, et al.
Published: (2024-04-01)

Case report: Eosinophilic fasciitis induced by pembrolizumab with high FDG uptake on 18F-FDG-PET/CT
by: Karim Amrane, et al.
Published: (2022-12-01)

Standardised uptake values of 2-deoxy-2-[18F]fluoro-d-glucose using PET/CT in normal cats
by: Y.K. Cho, et al.
Published: (2013-02-01)

Preoperative Hilar and Mediastinal Lymph Node Staging in Patients with Suspected or Diagnosed Lung Cancer: Accuracy of 18F-FDG-PET/CT:A Retrospective Cohort Study of 138 Patients
by: Fuad Damirov, et al.
Published: (2023-01-01)

Liver-FDG-uptake augments early PET/CT prognostic value for CD19-targeted CAR-T cell therapy in diffuse large B cell lymphoma
by: Michael Beck, et al.
Published: (2025-03-01)

Not everything that shines is gold, normal uptake in crista terminalis on FDG PET/CT masquerading as a tumor thrombus approaching right heart
by: Aiden Ghesani, et al.
Published: (2024-02-01)

Dynamic Whole-Body FDG PET/CT for Predicting Malignancy in Head and Neck Tumors and Cervical Lymphadenopathy
by: Gregor Horňák, et al.
Published: (2025-10-01)

Lung cancer-associated fibroblasts-mediated collagen deposition drives mediastinal lymph node metastasis in non-small cell lung cancer
by: Caoyang Chen, et al.
Published: (2025-06-01)

Added Value of Abnormal Lymph Nodes Detected with FDG-PET/CT in Suspected Vascular Graft Infection
by: Nick D. van Rijsewijk, et al.
Published: (2023-02-01)

Comparative Role of MDCT and FDG-PET/CT in the Diagnostic Evaluation of Mediastinal Mass Lesions: An Institutional Experience
by: Ravikanth Reddy
Published: (2022-09-01)

Comparative Analysis of Results of Transbronchial Needle Aspiration Biopsy of Mediastinal Lymph Nodes with Flexible and Rigid Tracheobronchoscopy for Verification of Mediastinal Lymphadenopathies
by: N. A. Samorodov, et al.
Published: (2023-07-01)

18 F-FDG PET/CT体积代谢参数在局限期小细胞肺癌预后的预测价值
by: 林晓平, et al.
Published: (2017-01-01)

Heterogeneous uptake of 18F-FDG and 18F-PSMA-1007 PET/CT in lung cancer and lymph node metastasis
by: Yuan Hu, et al.
Published: (2023-03-01)

The tumor‐to‐liver ratio of the standardized uptake value is a useful FDG‐PET/CT parameter for predicting malignant intraductal papillary mucinous neoplasm of the pancreas
by: Takeshi Utsunomiya, et al.
Published: (2022-09-01)

Assessment of the Effect of Blood Glucose Levels on Standardized Uptake Value (SUV) and 18F-FDG Uptake at Tumors and Normal PET Examinations
by: Marwa Safa Riyadh, et al.
Published: (2025-06-01)